The conceptual introduction of the "demyelinating Schwann cell" in peripheral demyelinating neuropathies

被引:31
|
作者
Park, Hwan Tae [1 ]
Kim, Jong Kuk [2 ]
Tricaud, Nicolas [3 ]
机构
[1] Dong A Univ, Coll Med, Dept Mol Neurosci, Peripheral Neuropathy Res Ctr, Busan, South Korea
[2] Dong A Univ, Coll Med, Dept Neurol, Peripheral Neuropathy Res Ctr, Busan, South Korea
[3] Univ Montpellier, INM, INSERM, U1051, Montpellier, France
基金
新加坡国家研究基金会; 欧洲研究理事会;
关键词
demyelination; myelin exocytosis; peripheral neuropathy; Schwann cells; segmental demyelination; Wallerian degeneration; EXPERIMENTAL ALLERGIC NEURITIS; WALLERIAN DEGENERATION; INTRANEURAL INJECTION; C-JUN; INFLAMMATORY NEUROPATHY; LANTERMAN INCISURES; ELECTRON-MICROSCOPE; MYELIN CLEARANCE; GENE-EXPRESSION; NERVOUS-SYSTEM;
D O I
10.1002/glia.23509
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Myelinating Schwann cells undergo irreversible demyelination in many demyelinating neuropathies that show complete demyelination of the internode. Dedifferentiation, reprogramming, and myelin clearance processes-which are specifically discussed in this article-appear to be shared by various demyelinating peripheral conditions, such as Wallerian degeneration, immune-mediated, and toxic demyelinating diseases. We propose to introduce the concept of the "demyelinating Schwann cell (DSC)" as a novel cell phenotype, which has specific properties required for myelin sheath clearance. We anticipate that the introduction of the DSC concept will provide a significant advance in understanding the pathophysiological mechanisms of demyelinating peripheral neuropathies.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [1] Molecular profiles of Schwann cells of demyelinating peripheral neuropathies
    Ten Asbrock, Anneloor L. M. A.
    Kwa, Marcel S. G.
    Saavedra, Jose T.
    Van Stuijvenberg, Leonie
    Baas, Frank
    NEURON GLIA BIOLOGY, 2007, 2 : S37 - S37
  • [2] Demyelinating neuropathies
    Kiernan, M. C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E511 - E512
  • [3] Multiple sclerosis and peripheral multifocal demyelinating neuropathies
    Kim, J. Y.
    Kwon, J. Y.
    Park, Kee Duk
    MULTIPLE SCLEROSIS, 2009, 15 (01): : 148 - 148
  • [4] Apheresis in treatment of the inflammatory demyelinating peripheral neuropathies
    Kincaid, JC
    THERAPEUTIC APHERESIS, 2002, 6 (01): : 53 - 56
  • [5] Demyelinating neuropathies
    Zhou, L
    Griffin, JW
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (03) : 307 - 313
  • [6] Excitability abnormalities of peripheral nerves in demyelinating neuropathies
    Verschueren, A
    Azulay, JP
    Attarian, S
    Pouget, J
    NEUROLOGY, 2002, 58 (07) : A351 - A351
  • [7] NEUROFASCIN AS A TARGET ANTIGEN IN PERIPHERAL DEMYELINATING NEUROPATHIES
    Mathey, E. K.
    Yan, W.
    Yuki, N.
    Ji, Q.
    Yiannikas, C.
    Pollard, J. D.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S84 - S84
  • [8] Gene therapy approaches targeting Schwann cells for demyelinating neuropathies
    Sargiannidou, Irene
    Kagiava, Alexia
    Kleopa, Kleopas A.
    BRAIN RESEARCH, 2020, 1728
  • [9] Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies
    Panjwani, M
    Truong, LD
    Eknoyan, G
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (02) : 279 - 283
  • [10] Therapeutic implications of protein homeostasis in demyelinating peripheral neuropathies
    Lee, Samuel M.
    Chin, Lih-Shen
    Li, Lian
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (09) : 1041 - 1043